- CTMX -0.61%
Shareholders in CytomX Therapeutics (NASDAQ:CTMX) are in the red if they invested five years ago
Yahoo Finance · 6 days ago
Open | 1.6400 |
High | 1.6900 |
Low | 1.6100 |
Mkt Cap | 127.01M |
P/E (TTM) | 7.76 |
Div & Yield | N/A & N/A |
Prev. Close | 1.6400 |
52 Wk. Low | 1.0400 |
52 Wk. High | 5.8500 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 41.46M | 76.40% ▲ |
Net Income | 13.79M | - |
Diluted EPS | 0.17 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.14 | - |
Q1 2024 | -$0.08 | $0.17 |
Q4 2023 | -$0.03 | $0.01 |
S&P 500^GSPC | 5,360.79+13.80 (+0.26%) |
Dow 30^DJI | 38,868.04+69.05 (+0.18%) |
Nasdaq^IXIC | 17,192.53+59.40 (+0.35%) |
Apple Inc.AAPL | 193.12-1.91% |
865.00+1.77% | |
160.34-4.49% |